Literature DB >> 20135829

Prevalence and clinical and molecular characterization of human metapneumovirus in children with acute respiratory infection in China.

Ni-guang Xiao1, Zhi-ping Xie, Bing Zhang, Xin-hui Yuan, Jing-rong Song, Han-chun Gao, Rong-fang Zhang, Yun-de Hou, Zhao-jun Duan.   

Abstract

BACKGROUND: Human metapneumovirus (HMPV), a newly discovered paramyxovirus, has been associated with acute respiratory tract infections (ARTIs). However, the prevalence and molecular characteristics of HMPV in China are still unclear.
METHODS: A total of 661 nasopharyngeal aspirates (NPA) specimens were collected from 661 children with ARTIs between December 2006 and November 2008. Specimens were screened for HMPV by reverse transcription-polymerase reaction. All positive amplification products were confirmed by sequencing.
RESULTS: HMPV was detected in 45 patients (6.80%) of the 661 children. The HMPV-infected patients were from 29 days to 9 years of age. A high incidence of HMPV infection (84.4%) was observed during the winter-spring season. Of the 45 HMPV-positive patients, 25 (55.6%) were co-infected with other respiratory viruses, and respiratory syncytial virus (RSV) was the most common additional respiratory virus. The most common clinical diagnosis was bronchopneumonia (57.8%) and cough (88.9%) was the most common clinical symptom. Phylogenetic analysis of the F gene revealed that 80% of the HMPV detected were A2, 2.2% were A1, and 17.8% were B1. Statistical analyses showed that sex, ages, seasons, and severity of the disease did not correlate with HMPV genotype (P = 0.986, 0.347, 0.660, 0.252), but viral coinfection with HMPV increased hospitalization rates (P = 0.005).
CONCLUSIONS: HMPV was frequently detected in the pediatric patients with ARTI in China. RSV was the most common coinfection virus and coinfection increased hospitalization rates. All HMPV subgroups except B2 cocirculated and there was no association found between HMPV genotypes and severity of disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20135829     DOI: 10.1097/inf.0b013e3181b56009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  16 in total

Review 1.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Increase human metapneumovirus mediated morbidity following pandemic influenza infection.

Authors:  Liora Regev; Tal Meningher; Musa Hindiyeh; Ella Mendelson; Michal Mandelboim
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

3.  Effect of in vitro syncytium formation on the severity of human metapneumovirus disease in a murine model.

Authors:  Laetitia Aerts; Marie-Hélène Cavanagh; Julia Dubois; Julie Carbonneau; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Marie-Ève Hamelin; Guy Boivin
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

4.  Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.

Authors:  Nina Moe; Sidsel Krokstad; Inger Heimdal Stenseng; Andreas Christensen; Lars Høsøien Skanke; Kari Ravndal Risnes; Svein Arne Nordbø; Henrik Døllner
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

5.  The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults.

Authors:  Xiang Yong Oong; Jack Bee Chook; Kim Tien Ng; Wei Zhen Chow; Kok Gan Chan; Nik Sherina Hanafi; Yong Kek Pang; Yoke Fun Chan; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  Virol J       Date:  2018-05-23       Impact factor: 4.099

6.  Human metapneumovirus in patients with respiratory tract infection in Kuwait.

Authors:  Mariam Al-Turab; Wassim Chehadeh; Fahd Al-Mulla; Widad Al-Nakib
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

7.  Human metapneumovirus-associated hospital admissions over five consecutive epidemic seasons: evidence for alternating circulation of different genotypes.

Authors:  Paola Apostoli; Sonia Zicari; Alessandra Lo Presti; Massimo Ciccozzi; Marco Ciotti; Arnaldo Caruso; Simona Fiorentini
Journal:  J Med Virol       Date:  2012-03       Impact factor: 2.327

8.  Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).

Authors:  Sumana Fathima; Bonita E Lee; Jennifer May-Hadford; Shamir Mukhi; Steven J Drews
Journal:  Viruses       Date:  2012-11-05       Impact factor: 5.048

Review 9.  Molecular epidemiology of respiratory viruses in virus-induced asthma.

Authors:  Hiroyuki Tsukagoshi; Taisei Ishioka; Masahiro Noda; Kunihisa Kozawa; Hirokazu Kimura
Journal:  Front Microbiol       Date:  2013-09-12       Impact factor: 5.640

10.  Human metapneumovirus associated with community-acquired pneumonia in children in Beijing, China.

Authors:  Guilan Lu; Jianguo Li; Zhengde Xie; Chunyan Liu; Li Guo; Guy Vernet; Kunling Shen; Jianwei Wang
Journal:  J Med Virol       Date:  2012-10-23       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.